Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation

Moda-Sava, R. N., Murdock, M. H., Parekh, P. K., Fetcho, R. N., Huang, B. S., Huynh, T. N., Witztum, J., Shaver, D. C., Rosenthal, D. L., Alway, E. J., Lopez, K., Meng, Y., Nellissen, L., Grosenick, L., Milner, T. A., Deisseroth, K., Bito, H., Kasai, H., Liston, C.·2019·Science
DOI 10.1126/science.aat8078

Cited by (644)

Items 601–644 of 644

  1. Ketamine’s Multifaceted Neuropharmacological and Neurobiological Actions
    Samuel Kohtala, Iina Annala · 2025 · Neuromethods
  2. In Vivo Positron Emission Tomography Imaging of Presynaptic Density Reveals Stress-Associated Synaptic Deficits Related to Behavioral and Molecular Alterations in Rats
    Ruth Asch, Nira Hernandez Martin, Rolando García-Milian, Krista Fowles, Ralph Dileone, Zhengxin Cai, Conor M. Liston, Irina Esterlis · 2025 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  3. Dynamic Processes Induced by Ketamine and Their Potential for Augmented Treatment Strategies in Neuropsychiatric Disorders
    Meng Li, Zümrüt Duygu Şen, Lena Vera Danyeli, Nooshin Javaheripour, Martin Walter · 2025 · Neuromethods
  4. Human in vivo assessment of ketamine binding of the serotonin transporter—follow up at a higher dose
    G. Schlosser, Matej Murgaš, Godber Mathis Godbersen, Sabine Reichel, L. Silberbauer, Lukas Nics, Dietmar Winkler, Thomas Stimpfl, Markus Hacker, Siegfried F. Kasper et al. · 2025 · Frontiers in Neuroscience
  5. Ketamine strengthens synaptic inputs to the dorsal raphé to boost serotonergic activity: pivotal for rapid antidepressant-like effects
    Soukaina Es-Safi, Céline Bourcier‐Lucas, Erika Abrial, Adeline Cathala, Thierry Lesté-Lasserre, Philippe De Deurwaerdère, Jean‐Michel Revest, Jean Mazella, Nasser Haddjeri, Guillaume Lucas · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  6. Spatiotemporal remodeling in habenula marks the onset of depression-related phenotypes
    Patricia Molina, Denys Osypenko, Josep Garnica, Quentin Amossé, Farha Bouteldja, Léa Camelot, Sarah Mondoloni, Mauro Congiu, Claudia Kathe, Manuel Mameli · 2026 · Nature Neuroscience
  7. Serotonin receptor 4 in the ventral CA3 regulates agomelatine-induced anxiolytic-like behaviors.
    Xiang-Hu Liu, Muhammad Naveed, Xiao-Yun Hu, Lin-Lin Zhu, Fan Meng, Qi-Gang Zhou, Jing Zhang · 2025 · Acta Pharmacologica Sinica
  8. Additional file 1 of Loss of glucocorticoid receptor phosphorylation contributes to cognitive and neurocentric damages of the amyloid-β pathway
    Yann Dromard, Margarita Arango-Lievano, Amélie M. Borie, Maheva Dedin, Pierre Fontanaud, Joan Torrent, Michael J. Garabedian, Stephen D. Ginsberg, Freddy D. Jeanneteau · 2022 · Figshare
  9. Fast-acting antidepressants trigger presynaptic BDNF release and structural plasticity at mouse mossy fiber-CA3 synapses
    Irem L Atasoy-Rodriguez, Kenneth W. Johnson, Kishan Patel, Haroon Arain, Syed Zaidi, Karl F. Herold, Teresa A. Milner, Hugh C. Hemmings, Jimcy Platholi · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  10. The Emerging Crisis in Non-Prescribed Ketamine Use: A Rapid Attenuation of Depression in Face of Abuse and “Chill-out” or Escapism Drug
    Kai Uwe Lewandrowski, Kenneth Blum, Sergio Schmidt, Rossano Kepler Alvim Fiorelli, Mark S. Gold, Kavya Mohankumar, Alireza Sharafshah, Debasis Bagchi, Albert Pinhasov, Morgan P. Lorio et al. · 2026 · Substance Use & Misuse
  11. Age-related moderation of adjunctive psychotherapy and early life stress effects on depression symptom reductions following ketamine treatment: Initial insights from a large, naturalistic sample
    Raquel Kosted, Alli Waddell, Ken Adolph, Gregory A. Fonzo · 2026 · Journal of Affective Disorders
  12. α 5 -GABA A allosteric modulation triggers and prolongs dopamine neuronal activity via AMPA receptors
    Areebah Ahmed, Mostafa El Mansari, Pierre Blier · 2026 · Journal of Psychopharmacology
  13. MDMA enhances prefrontal plasticity and representational drift during fear extinction
    Nitzan Geva, Sarah J. Jefferson, Emi Krishnamurthy, Tanner L. Anderson, Jocelyne A. Rondeau, Patrick H. Wehrle, Axel Fogaça Rosado, Christopher Pittenger, John H. Krystal, Alfred P. Kaye · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  14. The role of transcription factor Neurod2 in cortex development and its implications in neurodevelopmental disorders
    Karen Runge · 2022 · theses.fr (ABES)
  15. Exploring the molecular determinants of behavioral changes induced by ketamine at the nanoscale
    Floriane Uyttersprot · 2024 · theses.fr (ABES)
  16. Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects
    Zhen Xuen Brandon Low · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  17. Sex-Specific Reversal of Stress-Induced Depressogenic Behaviors by Inhibition of HMGB1, TLR4, and NF-κB Signaling
    Aslıhan Bahadır‐Varol, Bengisu Solgun, Gülce Küreli, Emre Cem Esen, Emine Eren‐Koçak · 2026 · Molecular Neurobiology
  18. On the meaning of “plasticity” in neuroscience and mental health research and its relation to the action of psychedelic therapy
    Robin Lester Carhart-Harris, Richard J. Zeifman, Lorenzo Pasquini, Bijurika Nandi, Cyrus Rohani-Shukla, Shayam Suseelan, Pedro A. M. Mediano, Fernando C W Rosas, Christopher Timmermann, Hannes Kettner et al. · 2026 · Frontiers in Neuroscience
  19. This is IT: How accelerated intermittent theta burst stimulation relieves depression symptoms
    Morteza Salimi, Dhakshin Ramanathan · 2026 · Cell
  20. Chronic corticosterone biases conflict-related behavior and abolishes ketamine's anticonflict effect in mice
    Natsuko HitoraーImamura, Yuki Nishida, Koki Kawazoe, Kota Ono, Haruto Kumamoto, Yuki Kurauchi, Hiroshi Katsuki · 2026 · Journal of Pharmacological Sciences
  21. NMDA Receptor Mediated Mechanisms in the Post-Stroke Brain: From Physiology to Pathology
    Han Gong, Xiang-Zheng Wang, Dan Liu, Wei-Jin Liu, DU Xiaoxia, Jia‐Sheng Rao · 2026 · Biomolecules
  22. ЕВОЛЮЦІЯ КЕТАМІНУ: ВІД ДИСОЦІАТИВНОГО АНЕСТЕТИКА ДО ШВИДКОДІЮЧОГО АНТИДЕПРЕСАНТА ТА НОВИХ ТЕРАПЕВТИЧНИХ ГОРИЗОНТІВ
    А. В. Чорномидз · 2026 · Здобутки клінічної і експериментальної медицини
  23. NMDA receptor–dependent structural plasticity links early life stress to persistent aggression
    Jessica T. Jacobs, Jacob C. Nordman · 2026 · Neurobiology of Stress
  24. Glucocorticoids-induced depressive-like behaviors in mice: oral ingestion of corticosterone or hydrocortisone − A comparative study
    Carina Ioná de Oliveira Torres, Victor A.D. Holanda, Matheus Cardoso de Oliveira, Anne Nathalia de Sousa-Silva, Clarissa de Almeida Moura, Edilson Dantas da Silva Junior, Elaine Cristina Gavioli · 2026 · Neuroscience Letters
  25. The Molecular Machinery of Synaptic Plasticity and Its Potential Role in the Aetiology of Schizophrenia
    BRIAN J. MORRIS · 2026 · Molecular Neurobiology
  26. Transcranial direct current stimulation alleviates depression-like behaviors by activating the ACC-ZI neural circuit
    Yue Wang, Kai Li, Tianzhi Yi, Bo Chen, Zibing Li, Haitong Chai, Huifei Hao, Hualin He, Xiaolang Du, S S Liu et al. · 2026 · Brain Research Bulletin
  27. Neural circuit dysfunction in major depressive disorder: a multiscale integrative perspective
    Dhanveer Ahamed Bathurutheen, Thenmoly K Damodaran · 2026 · Current Opinion in Physiology
  28. Bidirectional control of vesicular GABA release, LTP, and amotivation by GluN2D-selective allosteric modulators and ketamine
    Viktor Janos Oláh, Isabelle F. Witteveen, Tue G. Banke, Alexa M. Leahy, Ryan Keable, Riley E. Perszyk, Cara T. Khayat, TrangKimberly Thu Nguyen, Brianna J. Bixler, Frances Grace Ghinger et al. · 2026 · Cell Reports
  29. Subacute and long-term changes in cognitive functioning after administration of classic psychedelics, MDMA and ketamine: A systematic review of clinical and preclinical evidence
    Catherine Kelly, Bart J. Cooley, Lilith Zeng, Tristan P. Hurzeler, Victoria Manning, Gavan P. McNally, Joshua Watt, Paul Haber, Kirsten C. Morley · 2026 · Neuroscience & Biobehavioral Reviews
  30. Advances in the Study of Mechanisms Underlying the Role of Gut Microbiota in Depressive Disorders
    慧 张 · 2026 · Advances in Clinical Medicine
  31. (Es‑)Ketamin: Praxis-Update
    Stefan Vestring, Katharina Domschke, Claus Normann · 2026 · Der Nervenarzt
  32. Dysregulation of local inhibitory inputs onto laterodorsal tegmental nucleus cholinergic neurons drives depression-like behaviors in mice
    Yaling Xu, Jun Du, Xia Li, Huapeng Diao, Lili Nie, Chao Yuan, Jiani Li, Yizheng Wang · 2026 · Molecular Psychiatry
  33. Ketamine enhances ketogenic diet-induced resilience to activity-based anorexia of adult mice through hippocampal synaptic plasticity
    Jundi Wang, Olivia Ge, Yiru Dong, Emma J. Lee, Chiye J. Aoki · 2026 · Neuroscience
  34. The mPFC-reuniens-hippocampus pathway links brain circuitry and neural plasticity in antidepressant response
    Maxime Veleanu, Louise E. Schuberth, Antje Kilias, Jakob Weber, Jan Warneke, Lovis M. Würz, Tim Schwär, Rebecca Heck, Joelle Müller, David H. Sarrazin et al. · 2026 · Nature Communications
  35. Cofilin 1 overexpression in the ventral hippocampus partially alleviates depressive-like behaviors in postmenopausal depression model mice through the dynamics of dendrites/dendritic spines in relevant brain regions
    Zong-Hao Yu, Geng Chen, Ming-Jun Ge, Zhenqiang Zhang, Jun-Xian Shen, Chuan Pan, Fei Han, Ya-Ping Lu, Hui Xu · 2026 · Pharmacology Biochemistry and Behavior
  36. Reframing stress adaptation as a dynamic system failure along a threat-response continuum: towards a phase-specific, mechanism-driven framework
    Munan Lin, Munan Lin, Junqing Dong · 2026 · Molecular Psychiatry
  37. Enzephalopathien bei psychiatrischen Erkrankungen
    Julia Reiff, Dieter F. Braus · 2026 · Springer eBooks
  38. Neuroplasticity-Based Treatment Prioritization in Major Depressive Disorder: A Two-Cohort Study
    Talia Cohen Solal, Revital Amiaz, Moria Maman, Ziv Kassner, Guy Keller, Dror Ben Ami, Malgorzata Jaremko, Etay Aloni, Orit Goldman, Maurizio Fava M. D et al. · 2026 · medRxiv
  39. Ayahuasca Impairs Fear Memory Reconsolidation and Promotes Rapid Structural Plasticity in the Hippocampus and Prelimbic Cortex
    Daiane Momo Daneluz, Alana Sueli dos Santos, Silvana Regina de Melo, Rúbia Maria Weffort de Oliveira, Cristina Aparecida Jark Stern · 2026 · Molecular Neurobiology
  40. Ketamine’s mechanisms of action in major depressive disorder and treatment-resistant depression: Is brain topological change a candidate convergent systems-level pathway?
    Gia Han Le, Sabrina Wong, Simryn Selby, Roger S. McIntyre · 2026 · Asian Journal of Psychiatry
  41. 5-HT2A receptors in layer 5 pyramidal neurons mediate the neuroplastic but not the hallucinogenic effects of psilocybin
    Jacob Baker, Emily Kogan, Shaorong Ma, Ju Lu, Yi Zuo · 2026 · Nature Neuroscience
  42. Navigating the Complexities of Treatment-Resistant Depression in Late Life
    Carolina B. Cross, Vasilis C. Hristidis, Eric J. Lenze · 2026 · FOCUS The Journal of Lifelong Learning in Psychiatry
  43. Psychoplastogens to Reduce Persistent Cognitive Symptoms for Traumatic Brain Injury as a Chronic Condition
    Hoda K AbouEich, Ali Izadi, Jonathan Lifshitz, David E. Olson, Gene G. Gurkoff · 2026 · Journal of Neurotrauma
  44. HINT1 in ventral hippocampal GABAergic neurons mediates depressive-like behaviors
    Shao-fu Li, Dian-ying Liu, Hui Zhang, Rui-chao Wen, Huiling Hu, Jing-miao Xv, Dan Cheng, Yonghui Dang · 2026 · Molecular Psychiatry